T. Rowe Price Associates’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $486K | Buy |
|
|||||
|
2025
Q1 | $389K | Buy |
|
|||||
|
2024
Q4 | $447K | Buy |
|
|||||
|
2024
Q3 | $233K | Buy |
|
|||||
|
2024
Q2 | $262K | Buy |
|
|||||
|
2024
Q1 | $254K | Buy |
|
|||||
|
2023
Q4 | $256K | Sell |
|
|||||
|
2023
Q3 | $387K | Sell |
|
|||||
|
2023
Q2 | $360K | Buy |
|
|||||
|
2023
Q1 | $181K | Buy |
|
|||||
|
2022
Q4 | $124K | Buy |
|
|||||
|
2022
Q3 | $92K | Buy |
|
|||||
|
2022
Q2 | $87K | Buy |
|
|||||
|
2022
Q1 | $114K | Buy |
|
|||||
|
2021
Q4 | $131K | Sell |
|
|||||
|
2021
Q3 | $319K | Sell |
|
|||||
|
2021
Q2 | $691K | Sell |
|
|||||
|
2021
Q1 | $666K | Buy |
|
|||||
|
2020
Q4 | $301K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $141K | Buy |
|
|||||
|
2018
Q2 | $141K | Buy |
|
|||||
|
2018
Q1 | $151K | Buy |
|
|||||
|
2017
Q4 | $133K | Buy |
|